Accendra Health, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States. It offers a range of products and services for in-home care and delivery for diabetes treatment; home respiratory therapy, including home oxygen and non-invasive ventilation services; obstructive sleep apnea treatment, such as continuous positive airway pressure and bi-level positive airway pressure devices, and patient support services. The company also supplies other home medical equipment, patient care product lines including ostomy, wound care and negative pressure wound therapy, urology, incontinence, and other products and services. It serves patients and home health agencies. The company was formerly known as Owens & Minor, Inc. and changed its name to Accendra Health, Inc. in December 2025. Accendra Health, Inc. was founded in 1882 and is based in Glen Allen, Virginia.
Strategic Expansion | Explore Owens & Minor's $1.36 billion acquisition of Rotech, aimed at strengthening its position in the high-growth Patient Direct business |
Financial Challenges | Delve into the company's mixed Q3 results, revised guidance, and the implications of its recent CFO transition on financial stability |
Market Dynamics | Learn how Owens & Minor navigates industry shifts, including the impact of GLP-1 drugs and potential benefits from Chinese tariffs |
Analyst Perspectives | Discover varied analyst views on OMI's future, with price targets ranging from $14 to $23, reflecting both optimism and caution |
Metrics to compare | ACH | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipACHPeersSector | |
|---|---|---|---|---|
P/E Ratio | −2.5x | 9.7x | −0.5x | |
PEG Ratio | 0.01 | 2.24 | 0.00 | |
Price/Book | −0.6x | 2.9x | 2.6x | |
Price / LTM Sales | 0.1x | 0.9x | 3.2x | |
Upside (Analyst Target) | −14.8% | −19.7% | 44.7% | |
Fair Value Upside | Unlock | 60.2% | 5.7% | Unlock |